Krognes Steve E.Director
Sell $1.2M of disclosed value in Guardant Health, Inc. $GH.
Sell
Biotech & Oncology
- Last updated
- Jul 20, 2026
- Based on
- 191 actions
- Gurus considered
- 121
- Stocks covered
- 547
Biotechnology, oncology, immunology, genetic medicines, and clinical-stage therapeutics. This page tracks 191 investor, Congress, and insider actions tied to Biotech & Oncology within Healthcare Innovation, connecting the industry classification with the people and institutions currently showing activity. It gives context from 121 gurus across 547 stocks, so the feed can be read as an industry-level signal rather than a loose list of single-stock events.
Biotech & Oncology Smart Money Notes
AH Equity Partners Bio II, L.L.C.10% Owner
Sell $11.8M of disclosed value in Nautilus Biotechnology, Inc. $NAUT.
Sell
Stapley MarcDirector, CEO
Sell $6.9M of disclosed value in Veracyte Inc $VCYT.
Sell
Rothblatt Martine ADirector, Chair, CEO
Sell $4.4M of disclosed value in United Therapeutics Corporation $UTHR.
Sell
Randhawa SimratEVP, Head of R, D
Sell $1.5M of disclosed value in Dianthus Therapeutics, Inc. $DNTH.
Sell
Mahon Paul AEVP, GC
Sell $2.9M of disclosed value in United Therapeutics Corporation $UTHR.
Sell
Torley HelenDirector, President, CEO
Sell $2.4M of disclosed value in Halozyme Therapeutics, Inc. $HALO.
Sell
Meister Keith A.Director
Sell $106.4M of disclosed value in Illumina, Inc. $ILMN.
Sell
Orbimed Advisors LLC10% Owner
Buy $15M of disclosed value in Q32 Bio Inc. $QTTB.
Buy
Ewald Stephen PGC, Corp. Secy.
Sell $7.4M of disclosed value in Medpace Holdings Inc $MEDP.
Sell
Xu DiyongDirector, 10% Owner
Buy $15M of disclosed value in Q32 Bio Inc. $QTTB.
Buy
Sukhtian Ghiath M.Director, 10% Owner
Buy $12M of disclosed value in Outlook Therapeutics, Inc. $OTLK.
Buy
Callos AndrewEVP, CCO
Sell $1.1M of disclosed value in Cytokinetics, Incorporated $CYTK.
Sell
Fromkin Andrew J.Director
Sell $7.4M of disclosed value in Immunovant, Inc. $IMVT.
Sell
Edgemond JamesCFO, TREASURER
Sell $5.2M of disclosed value in United Therapeutics Corporation $UTHR.
Sell
Lefkofsky Eric PDirector, CEO, Chair, 10% Owner
Sell $7.8M of disclosed value in Tempus AI, Inc. $TEM.
Sell
AWM Investment Company, Inc.10% Owner
Sell $1.5M of disclosed value in 908 Devices Inc. $MASS.
Sell
Brynjelsen SeanDirector, President, CEO
Sell $3.8M of disclosed value in Eton Pharmaceuticals, Inc. $ETON.
Sell
Satter Muneer ADirector
Buy $3.3M of disclosed value in Annexon, Inc. $ANNX.
Buy
GC Corp.10% Owner
Buy $16.5M of disclosed value in Artiva Biotherapeutics, Inc. $ARTV.
Buy
Durcan Dermot MarkDirector
Buy $1.1M of disclosed value in Cencora Inc $COR.
Buy
Rothblatt Martine ADirector, Chair, CEO
Sell $4.3M of disclosed value in United Therapeutics Corporation $UTHR.
Sell
Saia John G.CLO
Sell $1.3M of disclosed value in Guardant Health, Inc. $GH.
Sell
Leproust Emily M.Director, CEO
Sell $3.1M of disclosed value in Twist Bioscience Corporation $TWST.
Sell
Rodgers Thomas LEVP, Chief Strategy, BDO
Sell $1.8M of disclosed value in McKesson Corp $MCK.
Sell
Edgemond JamesCFO, TREASURER
Sell $1.1M of disclosed value in United Therapeutics Corporation - Common Stock $UTHR.
Sell
Krempa DavidChief Business Officer
Sell $2.3M of disclosed value in Eton Pharmaceuticals, Inc. $ETON.
Sell
Wygant JonathanVP, CAO
Sell $1.1M of disclosed value in Veracyte Inc $VCYT.
Sell
Lau MicheleEVP, CLO
Sell $2.7M of disclosed value in McKesson Corp $MCK.
Sell
Freeman ChrisCCO
Sell $2.9M of disclosed value in Guardant Health Inc $GH.
Sell
Showing 31-60 of 191